{"id":2167,"date":"2025-04-14T09:56:49","date_gmt":"2025-04-14T07:56:49","guid":{"rendered":"https:\/\/www.access2meds.eu\/?p=2167"},"modified":"2025-04-14T09:56:54","modified_gmt":"2025-04-14T07:56:54","slug":"watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe","status":"publish","type":"post","link":"https:\/\/www.access2meds.eu\/es\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/","title":{"rendered":"Watch the ASCERTAIN Webinar on Reimbursement Decisions Across Europe"},"content":{"rendered":"\n

On 2 April 2025, Myeloma Patients Europe (MPE) hosted a webinar titled \u00abHow do different countries make decisions on reimbursing new medicines?\u00bb. The session provided valuable insights into how European health systems approach reimbursement processes, cost-effectiveness, and patient access to new treatments.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n
Speaker<\/h5>\n\n\n\n

Tom Belleman, PhD candidate at the Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, delivered a 45-minute presentation followed by a 30-minute Q&A session.<\/p>\n\n\n\n

Now Available Online<\/h5>\n\n\n\n

If you missed the live session, the full recording is available to watch here:
Watch the webinar on YouTube<\/a><\/p>\n\n\n\n

About the Speaker<\/h5>\n\n\n\n

Tom Belleman\u2019s research focuses on cost-effectiveness and market access for innovative health technologies, particularly in oncology. He holds degrees in Biomedical Sciences and Health Economics, Policy & Law.<\/p>\n\n\n\n

The webinar was organised by Myeloma Patients Europe (MPE).<\/p>\n","protected":false},"excerpt":{"rendered":"

On 2 April 2025, Myeloma Patients Europe (MPE) hosted a webinar titled \u00abHow do different countries make decisions on reimbursing new medicines?\u00bb. <\/p>\n","protected":false},"author":5,"featured_media":1450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[21,14,22,23,20],"class_list":["post-2167","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein","tag-health-technologies","tag-healthcare","tag-hta","tag-iht","tag-innovative-health-technologies"],"yoast_head":"\nWatch the ASCERTAIN Webinar on Reimbursement Decisions Across Europe - ASCERTAIN<\/title>\n<meta name=\"description\" content=\"On 2 April 2025, Myeloma Patients Europe (MPE) hosted a webinar titled "How do different countries make decisions on reimbursing new medicines?". The session provided valuable insights into how European health systems approach reimbursement processes, cost-effectiveness, and patient access to new treatments.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Watch the ASCERTAIN Webinar on Reimbursement Decisions Across Europe\" \/>\n<meta property=\"og:description\" content=\"On 2 April 2025, Myeloma Patients Europe (MPE) hosted a webinar titled "How do different countries make decisions on reimbursing new medicines?". The session provided valuable insights into how European health systems approach reimbursement processes, cost-effectiveness, and patient access to new treatments.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-14T07:56:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-14T07:56:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2005\" \/>\n\t<meta property=\"og:image:height\" content=\"1254\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lena Jessen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lena Jessen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/\"},\"author\":{\"name\":\"Lena Jessen\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\"},\"headline\":\"Watch the ASCERTAIN Webinar on Reimbursement Decisions Across Europe\",\"datePublished\":\"2025-04-14T07:56:49+00:00\",\"dateModified\":\"2025-04-14T07:56:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/\"},\"wordCount\":142,\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"keywords\":[\"health technologies\",\"healthcare\",\"HTA\",\"iht\",\"innovative health technologies\"],\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/\",\"name\":\"Watch the ASCERTAIN Webinar on Reimbursement Decisions Across Europe - ASCERTAIN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"datePublished\":\"2025-04-14T07:56:49+00:00\",\"dateModified\":\"2025-04-14T07:56:54+00:00\",\"description\":\"On 2 April 2025, Myeloma Patients Europe (MPE) hosted a webinar titled \\\"How do different countries make decisions on reimbursing new medicines?\\\". The session provided valuable insights into how European health systems approach reimbursement processes, cost-effectiveness, and patient access to new treatments.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"width\":2005,\"height\":1254},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/es\\\/pagina-de-inicio\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Watch the ASCERTAIN Webinar on Reimbursement Decisions Across Europe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\",\"name\":\"Lena Jessen\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Watch the ASCERTAIN Webinar on Reimbursement Decisions Across Europe - ASCERTAIN","description":"On 2 April 2025, Myeloma Patients Europe (MPE) hosted a webinar titled \"How do different countries make decisions on reimbursing new medicines?\". The session provided valuable insights into how European health systems approach reimbursement processes, cost-effectiveness, and patient access to new treatments.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/","og_locale":"es_ES","og_type":"article","og_title":"Watch the ASCERTAIN Webinar on Reimbursement Decisions Across Europe","og_description":"On 2 April 2025, Myeloma Patients Europe (MPE) hosted a webinar titled \"How do different countries make decisions on reimbursing new medicines?\". The session provided valuable insights into how European health systems approach reimbursement processes, cost-effectiveness, and patient access to new treatments.","og_url":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/","og_site_name":"ASCERTAIN","article_published_time":"2025-04-14T07:56:49+00:00","article_modified_time":"2025-04-14T07:56:54+00:00","og_image":[{"width":2005,"height":1254,"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","type":"image\/jpeg"}],"author":"Lena Jessen","twitter_card":"summary_large_image","twitter_creator":"@ASCERTAIN_EU","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Escrito por":"Lena Jessen","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/#article","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/"},"author":{"name":"Lena Jessen","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391"},"headline":"Watch the ASCERTAIN Webinar on Reimbursement Decisions Across Europe","datePublished":"2025-04-14T07:56:49+00:00","dateModified":"2025-04-14T07:56:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/"},"wordCount":142,"publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"image":{"@id":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","keywords":["health technologies","healthcare","HTA","iht","innovative health technologies"],"articleSection":["Allgemein"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/","url":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/","name":"Watch the ASCERTAIN Webinar on Reimbursement Decisions Across Europe - ASCERTAIN","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","datePublished":"2025-04-14T07:56:49+00:00","dateModified":"2025-04-14T07:56:54+00:00","description":"On 2 April 2025, Myeloma Patients Europe (MPE) hosted a webinar titled \"How do different countries make decisions on reimbursing new medicines?\". The session provided valuable insights into how European health systems approach reimbursement processes, cost-effectiveness, and patient access to new treatments.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","width":2005,"height":1254},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/watch-the-ascertain-webinar-on-reimbursement-decisions-across-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/"},{"@type":"ListItem","position":2,"name":"Watch the ASCERTAIN Webinar on Reimbursement Decisions Across Europe"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]},{"@type":"Person","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391","name":"Lena Jessen"}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/posts\/2167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/comments?post=2167"}],"version-history":[{"count":2,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/posts\/2167\/revisions"}],"predecessor-version":[{"id":2170,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/posts\/2167\/revisions\/2170"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/media\/1450"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/media?parent=2167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/categories?post=2167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/tags?post=2167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}